Lung cancer death rate halves since 1990s on new therapies

The New York Times reports that lung cancer mortality has dropped by half since the 1990s, attributed partly to novel treatments. The item is a general health trend piece, not tied to a specific event or policy change. It signals ongoing progress in oncology but carries no immediate market or geopolitical implications.